In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi sits down with Rachel Ellingson, chief strategy and corporate development officer at Solventum, recorded live at DeviceTalks Minnesota. Ellingson shares a rare perspective on leading medical device companies through major transitions, drawing on her experience at Zimmer Biomet during the ZimVie spinout and now at the helm of a business spun out from 3M Healthcare. She compares the two experiences and outlines what’s ahead for Solventum.

In our Future of MedTech Opportunities (FOMO) segment, Kayleen Brown speaks with Athar Mirza, VP of global infusion systems at Baxter International, about Baxter’s evolving role in connected health.

This episode is brought to you by Protolabs, https://www.protolabs.com.

Chris Newmarker and Sean Whooley break down the latest Newmarker’s Newsmakers, featuring headlines from Science, Olympus, Johnson & Johnson, and Stryker. Plus, Whooley shares insights from the American Diabetes Association meeting in Chicago, highlighting cutting-edge diabetes tech.

Thanks for tuning in to the DeviceTalks Weekly Podcast.

Enjoy this podcast? Follow DeviceTalks Weekly all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Join Olympus’ Melissa Elliott-Walker and Dr. Julie Yang as they discuss the vital relationship between Clinical Applications Specialists and HCPs.

Discover the impact of endoscopic ultrasound (EUS) in diagnosing and treating diseases, and learn about the latest advancements in this transformative technology.

ADDITIONAL RESOURCES:

1. Connect with your local CAS. They are ready to support your EUS practice and help you enhance patient care. For more information, visit: info.olympusamericamarketing.com/eus-cas

For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts.

* Dr. Julie Yang is a paid consultant of Olympus Corporation, its subsidiaries, and/or its affiliates. The content of this podcast was paid for by Olympus.

Enjoy this podcast? Follow OlympusTalks on all major podcast players: https://olympustalks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Paul LaViolette, president and CEO of Pulse Biosciences. LaViolette takes us back to the early days of the medical device industry and shares how close collaboration with interventionalists helped shape today’s MedTech landscape. We dive into one of the biggest deals in MedTech history — Boston Scientific’s acquisition of Guidant — and why it was crucial for the company’s survival despite its rocky road.

LaViolette also explains why investing in MedTech has never been more challenging and what drew him to lead Pulse Biosciences, a company pushing the boundaries of energy-based devices.

Before that, we’re proud to launch our new Future of MedTech Opportunities (FOMO) series, sponsored by Protolabs, https://www.protolabs.com/. In this installment, we speak with Anthony Jarc, vice president of digital and machine learning at Intuitive.

And as always, Chris Newmarker of Newmarker’s Newsmakers rounds up the biggest headlines, covering SS Innovations, Medtronic, Virtual Incision, and highlights from the American Diabetes Association’s annual meeting.

Thanks for tuning in to DeviceTalks Weekly.

Make sure to subscribe to the DeviceTalks Podcast Network so you never miss an episode: https://devicetalks.castos.com/subscribe

In this episode of Ortho Innovation Talks, Marc Mackey, senior vice president and general manager of Enabling Technologies at Enovis, breaks down how his team is building a next-generation platform that prioritizes precision, efficiency, and value. Mackey explains how augmented reality and AI are making orthopedic surgeries more accurate, efficient, and accessible — especially in outpatient environments like ASCs.

He details the evolution of Enovis’ AR-based navigation platform, ARVIS, from early prototypes to its current compact, cost-effective design that eliminates the need for bulky hardware. As adoption grows, Mackey highlights how surgeons are leveraging ARVIS for soft tissue balancing, gap assessment, and patient-specific alignment, while AI streamlines surgical planning and imaging segmentation.

This conversation comes to you courtesy of our sponsor, Regenity. To learn more about how Regenity can help support you, visit them at https://regenity.com.

Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe.

In this podcast episode, MassDevice Editor Chris Newmarker sits down with Christian Mazzi, CEO of Corcym — formerly LivaNova’s surgical heart valve business — about how it has transformed since it became an independent company under Gyrus Capital in 2021.

Next up is an effort to expand innovation beyond Corcym’s core heart valve portfolio to areas such as heart failure treatment. Mazzi, though, still has a lot to say about surgical heart valve replacement when speaking with MassDevice Editor in Chief Chris Newmarker. Surgical heart valve procedures are shifting toward being more laparoscopic, and surgical robotics applications are on the horizon. Even as transcatheter heart valves generate a lot of buzz in medtech, surgical heart valve innovation is getting exciting, too. Like the Arthurian heroes that Corcym names its products after, Mazzi and his company are on a quest.

But first Host Tom Salemi, DeviceTalks Managing Editor Kayleen Brown and Newmarker share their highlights of the wildly successful DeviceTalks Minnesota that took place on June 11. Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly podcast, we share Zimmer Biomet CEO Ivan Tornos’ stellar visit to DeviceTalks Boston where he laid out the orthopedics’ company’s plan to be the boldest MedTech in the world (and spilled some tea about how the company paired up with Arnold Schwarzenegger.)

Thank you to Protolabs for sponsoring this episode. Visit Protolabs.com for more information on how Protolabs works with medical device companies.

Tom Salemi and Chris Newmaker are joined by Heather Hudnut Page for this week’s Newmarker’s Newsmakers. The trio preview DeviceTalks Minnesota and highlight the region’s newsmakers including Solventum, Medtronic, Boston Scientific and Inspire Medical Systems.

Check out the agenda for the June 11 meeting at Minnesota.DeviceTalks.com.

Join us on June 12 for DeviceTalks Thursdays at Target Field! Buy your ticket to see the Twins game here. https://www.gofevo.com/event/DeviceTalks

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode: https://devicetalks.castos.com/subscribe

In this episode of AbbottTalks, we dive into the surprising origins of neuromodulation, kicking off with a shocker (literally)—treating headaches with electric fish.

Neuromodulation expert Yagna Pathak, PhD, Medical Science Manager of Medical Affairs at Abbott’s Neuromodulation business, explains how therapies like spinal cord and deep brain stimulation have evolved, detailing their impact on chronic pain and movement disorders. She outlines how Abbott is expanding neuromodulation applications through research in treatment-resistant depression and by integrating AI, wearables, and digital health tools.

Pathak also shares how connected care technologies—including the Neurosphere Virtual Clinic and the new Neurosphere Digital Health app—are improving patient outcomes. These platforms enhance access, enable timely interventions, and provide valuable educational resources for patients and providers.

Thank you to Cirtec Medical for sponsoring this episode of AbbottTalks. For more information on how Cirtec Medical works with medical device companies, visit https://www.cirtecmed.com/, and to learn more about Cirtec Medica’s Simplifi Platform, click: https://www.devicetalks.com/wp-content/uploads/2025/06/simpifi-overview_litsheet.pdf

Thank you for listening to the AbbottTalks Podcast. Click here to subscribe on your favorite podcast player: https://abbotttalks.castos.com/subscribe.

In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi speaks with Cecilia Soriano, global president of Infusion Therapies and Technologies at Baxter. Soriano details how the company responded after Hurricane Helene severely damaged its North Carolina facility last fall. With floodwaters halting operations and disrupting supplies—especially IV bags—Baxter had to make bold, fast decisions to get back online. Soriano shares key lessons in crisis response and supply chain resiliency.

This episode is sponsored by Aptyx. Go to Aptyx.com to find more information on how Aptyx works with medical device companies.

If you want to see the video reference in the talk, go to https://www.youtube.com/watch?v=j091JNt-SLc.

We’ll start the episode with this week’s Newsmarker’s Newsmakers. Managing Editor Kayleen Brown joins Salemi and MassDevice Editor Chris Newmarker to highlight the week’s biggest news from Zimmer Biomet, Hologic, Abbott, Boston Scientific, and Medtronic.

We also pinpoint our favorite parts of the agenda for DeviceTalks Minnesota, which is happening June 11 at the McNamara Alumni Center.

Register to attend at Minnesota.DeviceTalks.com! Use the code mentioned in the podcast to save 25%.